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There is ongoing concern for human health during spaceflights.  Of particular interest is 
the uncoupling of bone remodeling and its resultant effect on calcium metabolism and bone loss.  
The calculated average loss of bone mineral density (BMD) is approximately 1-1.5% per month 
of spaceflight.  The effect of decreased BMD on associated fractures in astronauts is not known.  
Currently on the International Space Station (ISS), bone loss is managed through dietary 
supplements and modifications and resistance exercise regimen.  As the duration of space flights 
increases, a review of the current methods available for the prevention of bone loss is warranted.  
The goal of this project is to review and summarize recent studies that have focused on 
maintaining BMD during exposure to microgravity.  Interventions were divided into physical 
(Table 1), nutritional (Table 2), or pharmacologic (Table 3) categories.   Physical modalities 
included resistance exercise, low level vibration, and low intensity pulsed 
ultrasound.  Nutritional interventions included altering protein, salt, and fat intake; and vitamin D 
supplementation.  Pharmacologic interventions included the use of bisphosphonates and beta 
blockers.   Studies reported outcomes based on bone density determined by DXA bone scan, 
micro-architecture of histology and microCT, and serum and urine markers of bone turnover.  
The ground analog models utilized to approximate osseous physiology in microgravity included 
human patients previously paralyzed or subjects confined to bedrest.  Ground analog animal 
models include paralysis, immobilization and ovariectomies. As a result of the extensive research 
performed there is a multi-modality approach available for the management of BMD during 
spaceflight that includes resistance training, nutrition and dietary supplements.  However, there 
is a paucity of literature describing a formalized tiered protocol to guide investigators through the 
progression from animal models to human patient ground analogs to experiments on the ISS.  
With regards to testing, further evaluation to determine the association between non-invasive 




Table 1.  Studies examining physical interventions for the management of BMD.  DXA = DXA Bone Scan, 
FEA = Finite Element Analysis, LIPUS = Low Intensity Pulsed Ultrasound 
 
Table 2.  Studies examining nutritional interventions for the management of BMD 
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